NCT07192666

Exosomes in Patients With Ocular Involvement of Sjögren's Syndrome

Exploratory Clinical Trial of Exosomes in Patients With Ocular Involvement of Sjögren's Syndrome

• Status: Not Yet Recruiting
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study is a single-center, multiple-dosing, prospective, nonrandom, single-arm trial.

Detailed description

This study is a single-center, multiple-dosing, prospective, nonrandom, single-arm trial. To evaluate the clinical safety and efficacy of exosomes in patients with ocular involvement of Sjögren's syndrome.

Conditions

• Sjögren's Syndrome

Interventions

Type	Name	Description
DRUG	Exosome Preparation	Each subject will have a single designated study eye; this eye will receive multiple instillations-one drop four times daily for 14 consecutive days.

Timeline

• Start date: 2025-09-15
• Primary completion: 2026-09-30
• Completion: 2026-09-30
• First posted: 2025-09-25
• Last updated: 2025-09-25